PubMed COVID-19 Clinical Care
39761 - 39770 of 58470 results found
COVID-19 as a catalyst for vaccine manufacturing: A South African experience
Description
COVID-19 highlighted inequitable vaccine distribution and the urgent need for vaccine manufacturing capacity on the African continent. This resulted in a burst of scientific engagement and international funding to augment capacity on the continent
The effects of prolactin on the immune system, its relationship with the severity of COVID-19, and its potential immunomodulatory therapeutic effect
Description
Prolactin (PRL) is an endocrine hormone secreted by the anterior pituitary gland that has a variety of physiological effects, including milk production, immune system regulation, and anti-inflammatory effects. Elevated levels of PRL have been found
Variability in PET image quality and quantification measured with a permanently filled 68Ge-phantom: a multi-center study
Description
CONCLUSION: The maximum variability of the RC values for the [^(18)F]FDG whole-body protocols was about 60%. The RC ranges of properly cross-calibrated scanners with PSF correction fitted to the EARL2 RC ranges for individual sphere sizes, but
Attributed causes of excess mortality during the COVID-19 pandemic in a south Indian city
Description
Globally, excess deaths during 2020-21 outnumbered documented COVID-19 deaths by 9.5 million, primarily driven by deaths in low- and middle-income countries (LMICs) with limited vital surveillance. Here we unravel the contributions of probable COVID
Broad host tropism of ACE2-using MERS-related coronaviruses and determinants restricting viral recognition
Description
Recently, two Middle East respiratory syndrome coronavirus (MERS-CoV) closely related to bat merbecoviruses, NeoCoV and PDF-2180, were discovered to use angiotensin-converting enzyme 2 (ACE2) for entry. The two viruses cannot use human ACE2
Post-authorization safety surveillance of Ad.26.COV2.S vaccine: Reports to the Vaccine Adverse Event Reporting System and v-safe, February 2021-February 2022
Description
CONCLUSION: Our review confirmed previously established safety risks for TTS and GBS and identified a potential safety concern for myocarditis.
The assessment of Twitter discourse on the new COVID-19 variant, XBB.1.5, through social network analysis
Description
CONCLUSION: Japan was actively engaged in evaluating the XBB.1.5 variant, with influential users playing a crucial role. The preference for sharing verified sources and the positive sentiment demonstrated a commitment to health awareness. We
Learning about unprecedented events: Agent-based modelling and the stock market impact of COVID-19
Description
We model the learning process of market traders during the unprecedented COVID-19 event. We introduce a behavioural heterogeneous agents' model with bounded rationality by including a correction mechanism through representativeness (Gennaioli et al
